Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    November 2024
  1. SUN B, Wang G, Chen G, Zhang Y, et al
    GNAO1 overexpression promotes neural differentiation of glioma stem-like cells and reduces tumorigenicity through TRIM21/CREB/HES1 axis.
    Oncogene. 2024 Nov 23. doi: 10.1038/s41388-024-03234.
    PubMed     Abstract available


  2. YU J, Han J, Yu M, Rui H, et al
    EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair.
    Oncogene. 2024 Nov 19. doi: 10.1038/s41388-024-03232.
    PubMed     Abstract available


    September 2024
  3. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Sep 26. doi: 10.1038/s41388-024-03177.
    PubMed    


    August 2024
  4. DAVE F, Herrera K, Lockley A, van de Weijer LL, et al
    Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.
    Oncogene. 2024 Aug 23. doi: 10.1038/s41388-024-03131.
    PubMed     Abstract available


  5. SONG Y, Zhang Y, Wang Z, Lin Y, et al
    CCL2 mediated IKZF1 expression promotes M2 polarization of glioma-associated macrophages through CD84-SHP2 pathway.
    Oncogene. 2024 Aug 7. doi: 10.1038/s41388-024-03118.
    PubMed     Abstract available


  6. HU J, Li X, Xu K, Chen J, et al
    CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A.
    Oncogene. 2024 Aug 4. doi: 10.1038/s41388-024-03116.
    PubMed     Abstract available


    July 2024
  7. SHAH K, Tang Y, Breakefield X, Weissleder R, et al
    Correction: Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
    Oncogene. 2024 Jul 23. doi: 10.1038/s41388-024-03109.
    PubMed    


    May 2024
  8. XU L, Ye Y, Tao Z, Wang T, et al
    Correction: O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2024 May 21. doi: 10.1038/s41388-024-03045.
    PubMed    


  9. XIE W, Wang J, Tian S, Zhao H, et al
    RNF126-mediated ubiquitination of FSP1 affects its subcellular localization and ferroptosis.
    Oncogene. 2024;43:1463-1475.
    PubMed     Abstract available


    February 2024
  10. SHENG H, Li H, Zeng H, Zhang B, et al
    Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
    Oncogene. 2024 Feb 14. doi: 10.1038/s41388-024-02967.
    PubMed     Abstract available


    November 2023
  11. XU L, Ye Y, Tao Z, Wang T, et al
    O-GlcNAcylation of melanophilin enhances radiation resistance in glioblastoma via suppressing TRIM21 mediated ubiquitination.
    Oncogene. 2023 Nov 10. doi: 10.1038/s41388-023-02881.
    PubMed     Abstract available


    September 2023
  12. TU KJ, Stewart CE, Hendrickson PG, Regal JA, et al
    Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma.
    Oncogene. 2023 Sep 23. doi: 10.1038/s41388-023-02845.
    PubMed     Abstract available


    August 2023
  13. WAN S, Liu C, Li C, Wang Z, et al
    AKIP1 accelerates glioblastoma progression through stabilizing EGFR expression.
    Oncogene. 2023 Aug 18. doi: 10.1038/s41388-023-02796.
    PubMed     Abstract available


    July 2023
  14. PAN JK, Lin WD, Kuo YL, Chen YC, et al
    ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in leptomeningeal metastasis of triple-negative breast cancer.
    Oncogene. 2023 Jul 19. doi: 10.1038/s41388-023-02769.
    PubMed     Abstract available


  15. NAVICKAS SM, Giles KA, Brettingham-Moore KH, Taberlay PC, et al
    The role of chromatin remodeler SMARCA4/BRG1 in brain cancers: a potential therapeutic target.
    Oncogene. 2023;42:2363-2373.
    PubMed     Abstract available


    June 2023
  16. PIPERI C, Markouli M, Gargalionis AN, Papavassiliou KA, et al
    Deciphering glioma epitranscriptome: focus on RNA modifications.
    Oncogene. 2023 Jun 15. doi: 10.1038/s41388-023-02746.
    PubMed     Abstract available


  17. EISENBARTH D, Wang YA
    Glioblastoma heterogeneity at single cell resolution.
    Oncogene. 2023 Jun 5. doi: 10.1038/s41388-023-02738.
    PubMed     Abstract available


  18. LIANG XQ, Avraham HK, Jiang S, Avraham S, et al
    Retraction Note: Genetic alterations of the NRP/B gene are associated with human brain tumors.
    Oncogene. 2023 Jun 2. doi: 10.1038/s41388-023-02741.
    PubMed    


  19. KAPOOR GS, O'Rourke DM
    Editorial Expression of Concern: SIRPa1 receptors interfere with the EGFRvIII signalosome to inhibit glioblastoma cell transformation and migration.
    Oncogene. 2023 Jun 1. doi: 10.1038/s41388-023-02740.
    PubMed    


    May 2023
  20. WEI J, Wang L, Zhang Y, Sun T, et al
    TRIM25 promotes temozolomide resistance in glioma by regulating oxidative stress and ferroptotic cell death via the ubiquitination of keap1.
    Oncogene. 2023 May 15. doi: 10.1038/s41388-023-02717.
    PubMed     Abstract available


  21. CORDNER R, Jhun M, Panwar A, Wang H, et al
    Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1.
    Oncogene. 2023 May 9. doi: 10.1038/s41388-023-02713.
    PubMed     Abstract available


  22. EL BABA R, Pasquereau S, Haidar Ahmad S, Monnien F, et al
    EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes.
    Oncogene. 2023 May 5. doi: 10.1038/s41388-023-02709.
    PubMed     Abstract available


  23. PAASSEN I, Williams J, Rios Arceo C, Ringnalda F, et al
    Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Oncogene. 2023;42:1661-1671.
    PubMed     Abstract available


    March 2023
  24. ZHOU P, Peng X, Tang S, Zhang K, et al
    E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.
    Oncogene. 2023 Mar 7. doi: 10.1038/s41388-023-02644.
    PubMed     Abstract available


    February 2023
  25. SAVASKAN NE, Seufert S, Hauke J, Trankle C, et al
    Correction: Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
    Oncogene. 2023 Feb 22. doi: 10.1038/s41388-023-02634.
    PubMed    


  26. WANG J, Xiao Z, Li P, Wu C, et al
    PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.
    Oncogene. 2023 Feb 15. doi: 10.1038/s41388-023-02624.
    PubMed     Abstract available


    December 2022
  27. YU T, Zhou F, Tian W, Xu R, et al
    EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.
    Oncogene. 2022 Dec 14. doi: 10.1038/s41388-022-02570.
    PubMed     Abstract available


  28. FIASCHETTI G, Castelletti D, Zoller S, Schramm A, et al
    Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma.
    Oncogene. 2022 Dec 7. doi: 10.1038/s41388-022-02555.
    PubMed    


    November 2022
  29. ZHAO S, Li B, Zhao R, Pan Z, et al
    Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2/ NF-kappaB pathway.
    Oncogene. 2022 Nov 17. pii: 10.1038/s41388-022-02542.
    PubMed     Abstract available


  30. SPINA R, Mills I, Ahmad F, Chen C, et al
    DHODH inhibition impedes glioma stem cell proliferation, induces DNA damage, and prolongs survival in orthotopic glioblastoma xenografts.
    Oncogene. 2022 Nov 7. pii: 10.1038/s41388-022-02517.
    PubMed     Abstract available


  31. BLAZQUEZ R, Chuang HN, Wenske B, Trigueros L, et al
    Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain.
    Oncogene. 2022;41:5008-5019.
    PubMed     Abstract available


    October 2022
  32. CHEN H, Chen X, Zhang Z, Bao W, et al
    Extracellular vesicles-transferred SBSN drives glioma aggressiveness by activating NF-kappaB via ANXA1-dependent ubiquitination of NEMO.
    Oncogene. 2022 Oct 31. pii: 10.1038/s41388-022-02520.
    PubMed     Abstract available


  33. SAHA G, Sarkar S, Mohanta PS, Kumar K, et al
    USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.
    Oncogene. 2022 Oct 15. pii: 10.1038/s41388-022-02486.
    PubMed     Abstract available


    September 2022
  34. LI M, Xu H, Qi Y, Pan Z, et al
    Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression.
    Oncogene. 2022 Sep 9. pii: 10.1038/s41388-022-02457.
    PubMed     Abstract available


    August 2022
  35. ZHAN Y, Qiao W, Yi B, Yang X, et al
    Dual role of pseudogene TMEM198B in promoting lipid metabolism and immune escape of glioma cells.
    Oncogene. 2022 Aug 29. pii: 10.1038/s41388-022-02445.
    PubMed     Abstract available


    July 2022
  36. YANG R, Li X, Wu Y, Zhang G, et al
    Correction: EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
    Oncogene. 2022 Jul 12. pii: 10.1038/s41388-022-02392.
    PubMed    


  37. XU H, Jin J, Chen Y, Wu G, et al
    GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair.
    Oncogene. 2022 Jul 2. pii: 10.1038/s41388-022-02397.
    PubMed     Abstract available


    June 2022
  38. LIU YQ, Luo M, Shi Y, Guo Y, et al
    Dicer deficiency impairs proliferation but potentiates anti-tumoral effect of macrophages in glioblastoma.
    Oncogene. 2022 Jun 28. pii: 10.1038/s41388-022-02393.
    PubMed     Abstract available


    May 2022
  39. JIANG Y, Zhao J, Xu J, Zhang H, et al
    Glioblastoma-associated microglia-derived exosomal circKIF18A promotes angiogenesis by targeting FOXC2.
    Oncogene. 2022 May 30. pii: 10.1038/s41388-022-02360.
    PubMed     Abstract available


    April 2022
  40. TYAGI A, Wu SY, Sharma S, Wu K, et al
    Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis.
    Oncogene. 2022 Apr 23. pii: 10.1038/s41388-022-02322.
    PubMed     Abstract available


  41. WU J, Shen S, Liu T, Ren X, et al
    Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.
    Oncogene. 2022 Apr 22. pii: 10.1038/s41388-022-02295.
    PubMed     Abstract available


  42. PENG W, Shi S, Zhong J, Liang H, et al
    CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression.
    Oncogene. 2022 Apr 22. pii: 10.1038/s41388-022-02296.
    PubMed     Abstract available


  43. BERNSTOCK JD, Kang KD, Klinger NV, Olsen HE, et al
    Targeting oncometabolism to maximize immunotherapy in malignant brain tumors.
    Oncogene. 2022 Apr 16. pii: 10.1038/s41388-022-02312.
    PubMed     Abstract available


  44. LANE R, Cilibrasi C, Chen J, Shah K, et al
    PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38(MAPK) signalling.
    Oncogene. 2022 Apr 7. pii: 10.1038/s41388-022-02294.
    PubMed     Abstract available


    March 2022
  45. TU J, Fang Y, Han D, Tan X, et al
    Correction: MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses.
    Oncogene. 2022 Mar 31. pii: 10.1038/s41388-022-02282.
    PubMed    


  46. TU Y, Xu L, Xu J, Bao Z, et al
    Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-beta signaling.
    Oncogene. 2022 Mar 25. pii: 10.1038/s41388-022-02275.
    PubMed     Abstract available


  47. TU J, Fang Y, Han D, Tan X, et al
    MicroRNA-22 represses glioma development via activation of macrophage-mediated innate and adaptive immune responses.
    Oncogene. 2022 Mar 12. pii: 10.1038/s41388-022-02236.
    PubMed     Abstract available


  48. ZHANG W, Chen S, Du Q, Bian P, et al
    CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1.
    Oncogene. 2022;41:1550-1562.
    PubMed     Abstract available


    February 2022
  49. CIRAKU L, Bacigalupa ZA, Ju J, Moeller RA, et al
    O-GlcNAc transferase regulates glioblastoma acetate metabolism via regulation of CDK5-dependent ACSS2 phosphorylation.
    Oncogene. 2022 Feb 22. pii: 10.1038/s41388-022-02237.
    PubMed     Abstract available


    November 2021
  50. ALZIAL G, Renoult O, Paris F, Gratas C, et al
    Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma.
    Oncogene. 2021 Nov 11. pii: 10.1038/s41388-021-02056.
    PubMed     Abstract available


  51. FINDLAY IJ, De Iuliis GN, Duchatel RJ, Jackson ER, et al
    Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.
    Oncogene. 2021 Nov 10. pii: 10.1038/s41388-021-02102.
    PubMed     Abstract available


    October 2021
  52. DI GIULIO S, Colicchia V, Pastorino F, Pedretti F, et al
    A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors.
    Oncogene. 2021;40:6143-6152.
    PubMed     Abstract available


    September 2021
  53. YE Z, Ai X, Zhao L, Fei F, et al
    Phenotypic plasticity of myeloid cells in glioblastoma development, progression, and therapeutics.
    Oncogene. 2021 Sep 23. pii: 10.1038/s41388-021-02010.
    PubMed     Abstract available


  54. FOUNTAIN DM, Smith MJ, O'Leary C, Pathmanaban ON, et al
    Correction: The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
    Oncogene. 2021 Sep 14. pii: 10.1038/s41388-021-01700.
    PubMed    


    August 2021
  55. MU M, Niu W, Zhang X, Hu S, et al
    Correction: LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Oncogene. 2021 Aug 16. pii: 10.1038/s41388-021-01990.
    PubMed    


    July 2021
  56. GUO M, Goudarzi KM, Abedi S, Pieber M, et al
    Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
    Oncogene. 2021 Jul 13. pii: 10.1038/s41388-021-01929.
    PubMed    


  57. WANG X, Zhang L, Song Y, Jiang Y, et al
    MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors.
    Oncogene. 2021;40:4615-4624.
    PubMed     Abstract available


    June 2021
  58. CHEN T, Zhang F, Liu J, Huang Z, et al
    Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells.
    Oncogene. 2021 Jun 29. pii: 10.1038/s41388-021-01922.
    PubMed     Abstract available


  59. ZHANG Y, Wang Y, Zhou D, Wang K, et al
    Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair.
    Oncogene. 2021 Jun 14. pii: 10.1038/s41388-021-01878.
    PubMed     Abstract available


  60. XI S, Cai H, Lu J, Zhang Y, et al
    The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis.
    Oncogene. 2021 Jun 9. pii: 10.1038/s41388-021-01854.
    PubMed     Abstract available


  61. JIANG Y, Wang Z, Ying C, Hu J, et al
    FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs.
    Oncogene. 2021;40:4094-4110.
    PubMed     Abstract available


    May 2021
  62. GUO M, Goudarzi KM, Abedi S, Pieber M, et al
    SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
    Oncogene. 2021 May 21. pii: 10.1038/s41388-021-01825.
    PubMed     Abstract available


    March 2021
  63. FUKASAWA K, Kadota T, Horie T, Tokumura K, et al
    CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway.
    Oncogene. 2021 Mar 16. pii: 10.1038/s41388-021-01745.
    PubMed     Abstract available


  64. YEO AT, Jun HJ, Appleman VA, Zhang P, et al
    EGFRvIII tumorigenicity requires PDGFRA co-signaling and reveals therapeutic vulnerabilities in glioblastoma.
    Oncogene. 2021 Mar 11. pii: 10.1038/s41388-021-01721.
    PubMed     Abstract available


  65. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    Correction: TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2021 Mar 2. pii: 10.1038/s41388-020-01620.
    PubMed    


  66. FAN Q, Gong T, Zheng C, Ng JMY, et al
    Statins repress hedgehog signaling in medulloblastoma with no bone toxicities.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01701.
    PubMed     Abstract available


    February 2021
  67. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    Correction: PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2021 Feb 8. pii: 10.1038/s41388-021-01644.
    PubMed    


  68. PAN JK, Lin CH, Kuo YL, Ger LP, et al
    MiR-211 determines brain metastasis specificity through SOX11/NGN2 axis in triple-negative breast cancer.
    Oncogene. 2021 Feb 3. pii: 10.1038/s41388-021-01654.
    PubMed     Abstract available


    January 2021
  69. ZHANG X, Liu Y, Dai L, Shi G, et al
    BATF2 prevents glioblastoma multiforme progression by inhibiting recruitment of myeloid-derived suppressor cells.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01627.
    PubMed     Abstract available


  70. KIM HJ, Kim JY, Jung CW, Lee YS, et al
    ANO1 regulates the maintenance of stemness in glioblastoma stem cells by stabilizing EGFRvIII.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01612.
    PubMed     Abstract available


  71. ZHANG Y, Kong Y, Ma Y, Ni S, et al
    Loss of COPZ1 induces NCOA4 mediated autophagy and ferroptosis in glioblastoma cell lines.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01622.
    PubMed     Abstract available


  72. WANG Z, Shi Y, Ying C, Jiang Y, et al
    Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-kappaB signaling.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01635.
    PubMed     Abstract available


    December 2020
  73. FOUNTAIN DM, Smith MJ, O'Leary C, Pathmanaban ON, et al
    The spatial phenotype of genotypically distinct meningiomas demonstrate potential implications of the embryology of the meninges.
    Oncogene. 2020 Dec 1. pii: 10.1038/s41388-020-01568.
    PubMed     Abstract available


    November 2020
  74. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    PubMed     Abstract available


  75. TAN IL, Arifa RDN, Rallapalli H, Kana V, et al
    CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.
    Oncogene. 2020 Nov 6. pii: 10.1038/s41388-020-01536.
    PubMed     Abstract available


    October 2020
  76. ANGEL I, Pilo Kerman O, Rousso-Noori L, Friedmann-Morvinski D, et al
    Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01506.
    PubMed     Abstract available


  77. EUSTACE NJ, Anderson JC, Warram JM, Widden HN, et al
    A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01511.
    PubMed     Abstract available


  78. LATTIER JM, De A, Chen Z, Morales JE, et al
    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.
    Oncogene. 2020 Oct 10. pii: 10.1038/s41388-020-01503.
    PubMed     Abstract available


  79. ANGOM RS, Mondal SK, Wang F, Madamsetty VS, et al
    Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme.
    Oncogene. 2020 Oct 1. pii: 10.1038/s41388-020-01462.
    PubMed     Abstract available


    September 2020
  80. MU M, Niu W, Zhang X, Hu S, et al
    LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01466.
    PubMed     Abstract available


    April 2020
  81. LUCIA K, Wu Y, Garcia JM, Barlier A, et al
    Hypoxia and the hypoxia inducible factor 1alpha activate protein kinase A by repressing RII beta subunit transcription.
    Oncogene. 2020;39:3367-3380.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.